Venture
![LOGO 8-01 LOGO 8-01](https://firstxfounder.com/wp-content/uploads/2018/07/LOGO-8-01-4-1024x1024.png)
Affiliations
SUNY
Technologies
Therapeutic
Indication
Basic Research
Drug Discovery
Molecular Diagnostic
Oncology
Orphan Diseases
Personalized Medicine
Website
www.nomocan.comUtilizing a novel immunologic approach, NomoCan Pharmaceuticals is developing a targeted therapy for the treatment and prognosis of the most aggressive human cancer, pancreatic cancer.
NomoCan Pharmaceuticals Team: